We are proud to announce that the project titled "Development of Biomarkers and Advanced Technological Warning Systems for the Diagnosis, Monitoring, and Treatment of Neuron Damage-Related Diseases," led by Prof. Dr. Oğuzhan Gündüz, faculty member of the Department of Metallurgy and Materials Engineering and Director of the Nanotechnology and Biomaterials Application and Research Center (NBUAM) at Marmara University, has been granted support under the TÜBİTAK 1004 Excellence Center Support Program.

The project, part of the "High Technology Platforms" initiative, is a collaboration between Marmara University, Istanbul University-Cerrahpaşa, Yıldız Technical University, Dokuz Eylül University, Yeditepe University, Gazi University, TÜBİTAK Marmara Research Center, RTA Laboratories Biological Products Pharmaceuticals and Machinery Industry Trade Inc., Izmir Biomedicine and Genome Center, and Biokido Medical Engineering Industry and Trade Ltd. The project will span 48 months and include a team of 19 researchers from Marmara University. The university is the project leader with a total budget of 65,983,649.60 TL.

The primary goal of the project is to develop hydrogel-based microneedles loaded with antiepileptic drugs and supported by an electric circuit for the treatment of drug-resistant epilepsy. These microneedles aim to control drug release during seizures using an electric field.

We congratulate our esteemed faculty members and the project team and wish them continued success.